With diabetes rates continuing to rise across Pakistan, Diabetic Retinopathy has become one of the country’s more common causes of preventable vision loss. The condition develops as prolonged high blood sugar damages the small blood vessels of the retina, initially causing blurred vision and, if left unmanaged, progressing toward significant sight loss. India has become a preferred destination for **Diabetic Retinopathy treatment for patients from Pakistan**, though it remains important to note that a definitive cure for this vascular condition is still a complex and ongoing pursuit within the medical field.
As part of a broader diabetic retinopathy treatment approach, stem cell-based therapy is regarded as an area of growing clinical interest for patients whose retinal blood vessels have been damaged by long-term high blood sugar. This form of treatment is explored as a supportive measure aimed at encouraging vascular and tissue repair, used alongside — never in place of — proper blood sugar management, which remains the most important factor in slowing disease progression.
Within a structured diabetic retinopathy treatment protocol, Mesenchymal stem cell injections delivered via the Retro-bulbar route have proven to be a dependable approach, usually requiring one or two sessions. This method has shown favorable results in supporting the regeneration of retina and vascular tissue affected by diabetic damage, with relevance extending across retinal pigment epithelium cells, macular cells, and photoreceptor cells.
Diabetic patients from Pakistan exploring treatment options are encouraged to connect with the Eye Stem Cell Center, which brings more than 12 years of focused experience with diabetes-related eye complications. Our team carefully reviews HbA1c history and retinal imaging before advising any patient on next steps.
Eye Stem Cell Center is one of the most trusted providers of Diabetic Retinopathy treatment in Pakistan.

